Epidemiology of human inmunodeficiency virus infection: delay in diagnosis

被引:11
作者
Carnicer-Pont, Dolors [1 ]
Vives, Nuria [1 ]
Casabona i Barbara, Jordi [1 ]
机构
[1] Ctr Estudis Epidemiol Infecc Transmissio Sexual &, Inst Catala Oncol, Barcelona, Spain
来源
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2011年 / 29卷 / 02期
关键词
Human inmunofeficiency virus infection; Epidemiological surveillance; Late diagnosis; ACTIVE ANTIRETROVIRAL THERAPY; HIV-1-INFECTED PATIENTS; COLLABORATIVE ANALYSIS; PERSONS AWARE; UNITED-STATES; HIV; TRANSMISSION; UNAWARE; COHORT; SPAIN;
D O I
10.1016/j.eimc.2010.11.010
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Epidemiological surveillance of HIV infection has made notably progress over the last decade, improving knowledge of its characteristics and adapting treatment accordingly. On the other hand, the delayed diagnosis of HIV infection is still an important problem to reduce transmission and improve epidemic control both national and internationally. Although the increased availability of new testing technologies over the last ten years, progress, although statistically significant,in reducing late diagnosis in Spain has been, insufficient in terms of public health, meaning that additional efforts should be put in place to review strategies and increase accessibility to tests, population awareness and decrease the lost opportunities for early diagnosis. (C) 2010 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:144 / 151
页数:8
相关论文
共 23 条
[1]   Late diagnosis of HIV in Europe: definitional and public health challenges [J].
Adler, A. ;
Mounier-Jack, S. ;
Coker, R. J. .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2009, 21 (03) :284-293
[2]  
[Anonymous], AIDS EP UPD
[3]   Late presentation of HIV infection: a consensus definition [J].
Antinori, A. ;
Coenen, T. ;
Costagiola, D. ;
Dedes, N. ;
Ellefson, M. ;
Gatell, J. ;
Girardi, E. ;
Johnson, M. ;
Kirk, O. ;
Lundgren, J. ;
Mocroft, A. ;
Monforte, A. d'Arminio ;
Phillips, A. ;
Raben, D. ;
Rockstroh, J. K. ;
Sabin, C. ;
Sonnerborg, A. ;
de Wolf, F. .
HIV MEDICINE, 2011, 12 (01) :61-64
[4]  
Beral V, 2004, AIDS, V18, P51, DOI [10.1097/01.aids.0000096908.73209.5d, 10.1097/00002030-200401020-00006]
[5]  
Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1
[6]   Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV [J].
Castilla, J ;
del Romero, J ;
Hernando, V ;
Marincovich, B ;
García, S ;
Rodríguez, C .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (01) :96-101
[7]   Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy:: a collaborative analysis of prospective studies [J].
Egger, M ;
May, M ;
Chêne, G ;
Phillips, AN ;
Ledergerber, B ;
Dabis, F ;
Costagliola, D ;
Monforte, AD ;
de Wolf, F ;
Reiss, P ;
Lundgren, JD ;
Justice, AC ;
Staszewski, S ;
Leport, C ;
Hogg, RS ;
Sabin, CA ;
Gill, MJ ;
Salzberger, B ;
Sterne, JAC .
LANCET, 2002, 360 (9327) :119-129
[8]  
*EUR CTR DIS PREV, 2008, HIV AIDS SURV EUR, P11
[9]  
*EUR CTR DIS PREV, 2006, M REP HIV PREV EUR A
[10]  
European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2008, HIV AIDS SURV EUR 20